ADD CONDITION

items per page

Medichoice Barrier

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 32 mg/1 g
Other brand names
Dosage form
Cloth
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2024
Label revision date
March 17, 2026
Active ingredient
Dimethicone 32 mg/1 g
Other brand names
Dosage form
Cloth
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2024
Label revision date
March 17, 2026
Manufacturer
O&M HALYARD, INC.
Registration number
OKM016
NDC root
39892-0951

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed to temporarily protect and relieve chapped or cracked skin, making it helpful for those experiencing dryness or irritation. It is particularly effective in preventing perineal dermatitis, which is a type of skin irritation that can occur in the genital area. By creating a barrier, it helps protect the skin from minor irritations associated with this condition, promoting comfort and healing.

Uses

This product is designed to temporarily protect and relieve chapped or cracked skin, making it a helpful option if you're dealing with dryness or irritation. It can also help prevent perineal dermatitis, which is a type of skin irritation that can occur in the genital area. Additionally, it provides protection from minor skin irritation associated with this condition, ensuring that your skin stays comfortable and healthy.

You can feel confident using this product, as there are no teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects reported.

Dosage and Administration

To use the barrier cream effectively, start by removing any wet or soiled garments from the affected area. Next, take a fresh barrier cream cloth and gently cleanse the soiled area to ensure it is clean. After using the cloth, make sure to discard it properly—do not flush it down the toilet.

Remember, this product is for individual use only, so avoid sharing it with others. After each use, reseal the label to keep the remaining product fresh and effective for your next application. Following these steps will help you maintain proper hygiene and maximize the benefits of the barrier cream.

What to Avoid

It's important to be aware of certain guidelines when using this medication. You should not take it if your condition worsens or does not improve within 7 days. This is a key safety measure to ensure that you are receiving the appropriate care for your health needs.

Currently, there are no specific contraindications, controlled substance classifications, or noted risks of abuse, misuse, or dependence associated with this medication. However, always consult with your healthcare provider if you have any concerns or questions about your treatment.

Side Effects

It's important to use this product only on the skin and to avoid contact with your eyes, ears, and mouth. If your condition does not improve within 7 days or worsens, you should stop using the product and consult a doctor.

Make sure to keep this product out of reach of children, and if it is swallowed, seek medical help or contact a Poison Control Center immediately.

Warnings and Precautions

This product is intended for external use only, so please avoid contact with your eyes, ears, and mouth. It's important to keep it out of reach of children unless an adult is supervising. If a child accidentally swallows the product, seek medical help or contact a Poison Control Center immediately.

If your condition worsens or does not improve within 7 days of using this product, stop using it and consult your doctor for further advice. Your health and safety are important, so please take these precautions seriously.

Overdose

If you or someone else has swallowed too much of this medication, it’s important to seek medical help immediately. You can do this by contacting a Poison Control Center or going to the nearest emergency room.

Signs of an overdose can vary, but they may include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms, don’t wait—get help right away. Remember, acting quickly can make a significant difference in the outcome.

Pregnancy Use

When considering the use of MediChoice Barrier - dimethicone cloth during pregnancy, it's important to note that there is no specific information available regarding its safety, dosage adjustments, or any special precautions for pregnant individuals. This means that the effects of this product on pregnancy have not been clearly studied or established.

If you are pregnant or planning to become pregnant, it is always best to consult with your healthcare provider before using any new products. They can provide personalized advice and help you make informed decisions about your health and the health of your baby.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to know that there is no specific information available regarding the use of this medication during nursing. This means that the effects on breast milk and your baby are not clearly defined.

Since there are no guidelines or precautions provided, it’s a good idea to consult with your healthcare provider to discuss any potential risks and to ensure the safety of both you and your infant while breastfeeding.

Pediatric Use

It's important to keep this medication out of reach of children unless an adult is supervising. If a child accidentally swallows it, seek medical help or contact a Poison Control Center immediately.

When using washcloths, make sure they are not too hot, as this can cause burns. Remember that wearing gloves can reduce your ability to feel heat, so always check the temperature carefully, especially for infants or individuals with sensitive skin.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

It appears that there is no specific information regarding renal impairment (kidney problems) in the provided text. Therefore, there are no guidelines, dosage adjustments, or monitoring instructions to share for patients with kidney issues. If you have concerns about how your kidney health may affect your medication or treatment, it's important to discuss this with your healthcare provider for personalized advice.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines, dosage adjustments, or special monitoring instructions provided for your condition in the available information. This means that the medication may not have been studied in depth for its effects on individuals with liver impairment.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that your treatment is safe and effective based on your individual health needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any lab tests you may be undergoing. This way, you can receive the best possible care tailored to your needs.

Storage and Handling

To ensure the best use of your product, store it at room temperature. After each use, remember to discard the wipe and do not flush it down the toilet. Reseal the label between uses to maintain freshness. If you choose to heat the package, do so in the microwave for no longer than 45 seconds, and be sure to check the temperature of the washcloths afterward, as microwave wattage can vary.

It's important to ensure that the washcloths are not excessively hot, especially when using them on infants, unresponsive individuals, or those with sensitive skin. Keep in mind that wearing gloves can reduce your sensitivity to heat, so monitor the temperature closely to avoid any burns.

Additional Information

You will apply this medication topically, which means you will apply it directly to the skin. There are no additional details available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences related to this medication.

FAQ

What is the primary use of this drug?

This drug temporarily protects and helps relieve chapped or cracked skin, and helps prevent perineal dermatitis.

Are there any contraindications for this drug?

No contraindications are listed for this drug.

What should I do if my condition worsens?

If your condition worsens or does not improve within 7 days, stop use and consult a doctor.

Is this drug safe for use during pregnancy?

No specific information regarding safety during pregnancy is provided in the drug insert.

How should I store this drug?

Store at room temperature and reseal the label between uses.

What precautions should I take when using this drug?

For external use only; keep out of eyes, ears, and mouth, and keep out of reach of children except with adult supervision.

Can I use this drug if I have kidney or liver problems?

No specific information regarding use in patients with kidney or liver problems is provided.

How should I dispose of used wipes?

Discard the wipe after use and do not flush.

What should I do if I accidentally swallow this drug?

If swallowed, get medical help or contact a Poison Control Center right away.

Can I heat the wipes before use?

If heating is desired, heat the entire package in the microwave for no longer than 45 seconds and check the temperature to ensure it is not excessively hot.

Packaging Info

Below are the non-prescription pack sizes of Medichoice Barrier (dimethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Medichoice Barrier.
Details

Drug Information (PDF)

This file contains official product information for Medichoice Barrier, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available.

Uses and Indications

This drug is indicated for the temporary protection and relief of chapped or cracked skin. It is also indicated for the prevention of perineal dermatitis and provides protection against minor skin irritation associated with this condition.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the following procedures are adhered to for the safe and effective administration of the product.

Prior to application, it is essential to remove any wet or soiled garments from the patient. The affected area should then be cleansed using a fresh barrier cream cloth to ensure proper hygiene and preparation for treatment. After use, the cleansing wipe must be discarded appropriately; it should not be flushed down the toilet.

This product is intended for individual use only. To maintain the integrity of the product, the label should be resealed between uses to prevent contamination and preserve efficacy.

Contraindications

Use is contraindicated if the condition worsens or does not improve within 7 days.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, ears, and mouth to prevent irritation or adverse reactions. In the event that the condition worsens or fails to improve within 7 days of use, it is advised to discontinue application and seek medical consultation.

This product should be kept out of reach of children, and adult supervision is recommended during use. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is strongly recommended.

Side Effects

Patients should be aware that the product is intended for external use only and must be kept out of the eyes, ears, and mouth to prevent adverse effects. In the event that the condition worsens or does not improve within 7 days of use, it is advised to stop using the product and consult a healthcare professional.

Additionally, the product should be kept out of reach of children, except when under adult supervision. If the product is swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Medichoice Barrier (dimethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Medichoice Barrier.
Details

Pediatric Use

Pediatric patients should be kept out of reach of children except under adult supervision. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

When using washcloths for pediatric care, it is crucial to ensure that the temperature is not excessively hot. The use of gloves may reduce sensitivity to heat; therefore, caregivers must closely monitor the heat level, particularly when treating infants, unresponsive individuals, or those with sensitive skin.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of MediChoice Barrier - dimethicone cloth during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks when recommending this product during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as specific recommendations are not provided in the current labeling.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring based on individual patient circumstances.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is recommended to ensure optimal care and management.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children, ensuring that it is only used under adult supervision. In the event of accidental ingestion, patients should be instructed to seek medical assistance or contact a Poison Control Center immediately.

Additionally, patients should be informed to discontinue use and consult a healthcare professional if their condition worsens or does not show improvement within 7 days. This guidance is essential for ensuring patient safety and effective management of their condition.

Storage and Handling

The product is supplied in a package that should be stored at room temperature. It is important to discard each wipe after use and to avoid flushing them down the toilet. To maintain product integrity, the label should be resealed between uses.

If heating of the wipes is desired, the entire package may be heated in a microwave for no longer than 45 seconds. Users should check the temperature of the cloths, as microwave wattage can vary significantly. Care should be taken to ensure that the washcloths do not become excessively hot. It is also noted that gloves may diminish sensitivity to heat, so users should closely monitor the heat level, especially when using the product on infants, unresponsive individuals, or those with sensitive skin.

Additional Clinical Information

The route of administration for the medication is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Medichoice Barrier, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Medichoice Barrier, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.